LAURICE INGRAM: Open Payments
NPI 1932745999 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 35 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $326 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $617 |
| Gilead Sciences, Inc. | 16 | $451 |
| GENZYME CORPORATION | 1 | $124 |
| ViiV Healthcare Company | 3 | $90 |
| Exact Sciences Corporation | 3 | $51 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Phadia US Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: Wegovy, Ozempic, Biktarvy, DUPIXENT, CABENUVA, Cologuard Collection Kit, DOVATO, Descovy.
Industry payments across NC — which companies pay providers there.
